(Q38107244)

29 August 2017

title

Hepatoselectivity and the evolution of insulin (English)

1 reference

29 August 2017

R Herring

1

1 reference

29 August 2017

R H Jones

series ordinal

2

1 reference

29 August 2017

D L Russell-Jones

series ordinal

3

1 reference

29 August 2017

language of work or name

1 reference

16 May 2013

1 reference

Diabetes, Obesity and Metabolism

29 August 2017

published in

1 reference

29 August 2017

volume

16

1 reference

29 August 2017

issue

1

1 reference

29 August 2017

page(s)

1-8

1 reference

Insulin's direct effects on the liver dominate the control of hepatic glucose production

29 August 2017

cites work

1 reference

Regulation by insulin of gluconeogenesis in isolated rat hepatocytes

21 January 2018

1 reference

Where does insulin resistance start? The brain

21 January 2018

1 reference

Contributions by kidney and liver to glucose production in the postabsorptive state and after 60 h of fasting.

21 January 2018

1 reference

Non-esterified fatty acids and the liver: why is insulin secreted into the portal vein?

21 January 2018

1 reference

Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C. elegans insulin gene family

21 January 2018

1 reference

Structural basis of the aberrant receptor binding properties of hagfish and lamprey insulins.

21 January 2018

1 reference

Enhanced binding affinity of chicken insulin in rat liver membranes and human lymphocytes: relationship tothe kinetic properties of the hormone- receptor interaction

21 January 2018

1 reference

The Insulin Receptor in Vertebrates Is Functionally More Conserved during Evolution than Insulin Itself

21 January 2018

1 reference

Biological properties of chemically modified insulins. I. Biological activity of proinsulin and insulin modified at A1-glycine and B29-lysine

21 January 2018

1 reference

21 January 2018

1 reference

Glucose and free fatty acid turnover in normal subjects and in diabetic patients before and after insulin treatment

21 January 2018

1 reference

Comparison of the effects on glucose and lipid metabolism of equipotent doses of insulin detemir and NPH insulin with a 16-h euglycaemic clamp

21 January 2018

1 reference

Growth hormone and diabetes mellitus. A review of sixty-three years of medical research and a glimpse into the future?

21 January 2018

1 reference

Improved glycemic control with intraperitoneal versus subcutaneous insulin in type 1 diabetes: a randomized controlled trial

21 January 2018

1 reference

The effect of systemic venous drainage of the pancreas on insulin sensitivity in dogs

21 January 2018

1 reference

Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but no effect on lipid metabolism in type 1 diabetes

21 January 2018

1 reference

Comparison of intraperitoneal and subcutaneous insulin administration on lipids, apolipoproteins, fuel metabolites, and hormones in type I diabetes mellitus.

21 January 2018

1 reference

Why intraperitoneal delivery of insulin with implantable pumps in NIDDM?

21 January 2018

1 reference

Results of pancreas transplantation with portal venous and enteric drainage.

21 January 2018

1 reference

International trial of the Edmonton protocol for islet transplantation.

21 January 2018

1 reference

Effect of thyroid hormone binding proteins on insulin receptor binding of B1-thyronine-insulin analogues

21 January 2018

1 reference

Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo

21 January 2018

1 reference

Differential effects of insulin detemir and neutral protamine Hagedorn (NPH) insulin on hepatic glucose production and peripheral glucose uptake during hypoglycaemia in type 1 diabetes

21 January 2018

1 reference

Insulin detemir reduces weight gain as a result of reduced food intake in patients with type 1 diabetes

21 January 2018

1 reference

Insulin degludec in type 1 diabetes: a randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine.

21 January 2018

1 reference

A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes

21 January 2018

1 reference

Effect of dexamethasone on hepatic glucose and insulin metabolism after oral glucose in conscious dogs

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/DOM.12117

1 reference

29 August 2017

1 reference